FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023951667> ?p ?o ?g. }

• W2023951667 endingPage "533" @default.
• W2023951667 startingPage "526" @default.
• W2023951667 abstract "A prospective phase II trial was carried out to evaluate an accelerated chemotherapy (CT) regimen followed by hyperfractionated radiation therapy (RT) in previously untreated Stage III-IV, operable (total laryngectomy), head and neck cancer patients. The current study evaluates overall survival, loco-regional control, organ preservation rates and toxicity. Between April 1997 and December 2002, 68 patients with advanced head and neck cancer were treated with 3 cycles of induction CT (cisplatin and 5-fluorouracil; days 1, 14, and 28) followed by hyperfractionated RT (7440 cGy/62 fractions). Sixty patients received the planned RT-CT treatment. Two months after the end of RT, 96% of patients had a clinical complete remission of the primary and 66% of the neck disease. At a median follow-up of 32 months, the 3-year overall and disease-free survival rates were 66% and 76%, respectively. Seven patients recurred on the primary site, 1 on the neck and 2 patients only had distant metastases. The organ preservation rate was 73%. Acute grade 3-4 mucositis occurred in 75% of patients and an 18% rate of CT-related cardiotoxicity was reported. The accelerated CT-RT regimen achieves a high rate of larynx preservation albeit with considerable toxicity. The current prospective clinical trial was approved by the Ethics Committee of the Centro di Riferimento Oncologico (C.R.O.) on May 27, 1996, # CRO-02-96. Written informed consent was required from all patients entering the study." @default.
• W2023951667 created "2016-06-24" @default.
• W2023951667 creator A5002166345 @default.
• W2023951667 creator A5011271923 @default.
• W2023951667 creator A5021793394 @default.
• W2023951667 creator A5025613183 @default.
• W2023951667 creator A5038699632 @default.
• W2023951667 creator A5047620515 @default.
• W2023951667 creator A5048548828 @default.
• W2023951667 creator A5060326230 @default.
• W2023951667 creator A5065834832 @default.
• W2023951667 creator A5071354389 @default.
• W2023951667 creator A5086937257 @default.
• W2023951667 date "2005-05-01" @default.
• W2023951667 modified "2023-10-18" @default.
• W2023951667 title "Neoadjuvant accelerated chemotherapy followed by hyperfractionated radiation therapy in patients with operable, locally advanced head and neck carcinoma" @default.
• W2023951667 cites W117021016 @default.
• W2023951667 cites W1968741994 @default.
• W2023951667 cites W1968768545 @default.
• W2023951667 cites W1970351776 @default.
• W2023951667 cites W1979300931 @default.
• W2023951667 cites W1990148861 @default.
• W2023951667 cites W2000749182 @default.
• W2023951667 cites W2022395184 @default.
• W2023951667 cites W2036005555 @default.
• W2023951667 cites W2046603314 @default.
• W2023951667 cites W2050332814 @default.
• W2023951667 cites W2066677235 @default.
• W2023951667 cites W2092354917 @default.
• W2023951667 cites W2100961085 @default.
• W2023951667 cites W2129226862 @default.
• W2023951667 cites W2139984188 @default.
• W2023951667 cites W2140169153 @default.
• W2023951667 cites W2145863615 @default.
• W2023951667 cites W2146148650 @default.
• W2023951667 cites W2151415400 @default.
• W2023951667 cites W2152609192 @default.
• W2023951667 cites W2167805334 @default.
• W2023951667 cites W2172200669 @default.
• W2023951667 cites W2326811942 @default.
• W2023951667 cites W2331395194 @default.
• W2023951667 doi "https://doi.org/10.1016/j.oraloncology.2004.12.013" @default.
• W2023951667 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15878759" @default.
• W2023951667 hasPublicationYear "2005" @default.
• W2023951667 type Work @default.
• W2023951667 sameAs 2023951667 @default.
• W2023951667 citedByCount "11" @default.
• W2023951667 countsByYear W20239516672023 @default.
• W2023951667 crossrefType "journal-article" @default.
• W2023951667 hasAuthorship W2023951667A5002166345 @default.
• W2023951667 hasAuthorship W2023951667A5011271923 @default.
• W2023951667 hasAuthorship W2023951667A5021793394 @default.
• W2023951667 hasAuthorship W2023951667A5025613183 @default.
• W2023951667 hasAuthorship W2023951667A5038699632 @default.
• W2023951667 hasAuthorship W2023951667A5047620515 @default.
• W2023951667 hasAuthorship W2023951667A5048548828 @default.
• W2023951667 hasAuthorship W2023951667A5060326230 @default.
• W2023951667 hasAuthorship W2023951667A5065834832 @default.
• W2023951667 hasAuthorship W2023951667A5071354389 @default.
• W2023951667 hasAuthorship W2023951667A5086937257 @default.
• W2023951667 hasConcept C121608353 @default.
• W2023951667 hasConcept C126322002 @default.
• W2023951667 hasConcept C141071460 @default.
• W2023951667 hasConcept C188816634 @default.
• W2023951667 hasConcept C2776530083 @default.
• W2023951667 hasConcept C2776611710 @default.
• W2023951667 hasConcept C2776694085 @default.
• W2023951667 hasConcept C2778496288 @default.
• W2023951667 hasConcept C2780474809 @default.
• W2023951667 hasConcept C2781157581 @default.
• W2023951667 hasConcept C2781413609 @default.
• W2023951667 hasConcept C509974204 @default.
• W2023951667 hasConcept C535046627 @default.
• W2023951667 hasConcept C71924100 @default.
• W2023951667 hasConceptScore W2023951667C121608353 @default.
• W2023951667 hasConceptScore W2023951667C126322002 @default.
• W2023951667 hasConceptScore W2023951667C141071460 @default.
• W2023951667 hasConceptScore W2023951667C188816634 @default.
• W2023951667 hasConceptScore W2023951667C2776530083 @default.
• W2023951667 hasConceptScore W2023951667C2776611710 @default.
• W2023951667 hasConceptScore W2023951667C2776694085 @default.
• W2023951667 hasConceptScore W2023951667C2778496288 @default.
• W2023951667 hasConceptScore W2023951667C2780474809 @default.
• W2023951667 hasConceptScore W2023951667C2781157581 @default.
• W2023951667 hasConceptScore W2023951667C2781413609 @default.
• W2023951667 hasConceptScore W2023951667C509974204 @default.
• W2023951667 hasConceptScore W2023951667C535046627 @default.
• W2023951667 hasConceptScore W2023951667C71924100 @default.
• W2023951667 hasIssue "5" @default.
• W2023951667 hasLocation W20239516671 @default.
• W2023951667 hasLocation W20239516672 @default.
• W2023951667 hasOpenAccess W2023951667 @default.
• W2023951667 hasPrimaryLocation W20239516671 @default.
• W2023951667 hasRelatedWork W1572341506 @default.
• W2023951667 hasRelatedWork W2035047172 @default.
• W2023951667 hasRelatedWork W2038475217 @default.
• W2023951667 hasRelatedWork W2096734466 @default.
• W2023951667 hasRelatedWork W2380931084 @default.

• next